Radio Cadena Agramonte emisiora de Camagüey
Moscow, Dec. 22 - A Chinese company announced positive results in a clinical trial of an implantable neurochip that allowed a paraplegic patient to control external devices using only his thoughts.
The test was conducted as part of the second clinical trial of an invasive brain-machine interface developed by teams from the Center of Excellence in Brain Science and Intelligent Technology of the Chinese Academy of Sciences, in collaboration with Huashan Hospital, affiliated with Fudan University, and several technology companies.
According to the researchers, the patient, a middle-aged man with quadriplegia caused by a cervical injury, was able to operate a smart wheelchair to move around his neighborhood and control a robot dog as an extension of his own body, even to pick up food for delivery.
The scientific team noted that the goal now is to accelerate the transition of this technology to real clinical applications, promoting its practical validation and integration with various smart devices, with the aim of boosting the development and adoption of brain-machine interfaces in China.
Neuralink, owned by Elon Musk, has helped many people with degenerative diseases or injuries that have left them unable to move. Recently, the company succeeded in implanting a second brain chip, allowing Alex Conley, who lost the movement of his limbs, to control a robotic assistive arm with his mind. (Text and photo: RT)
